Former Cerebral vice president Matthew Truebe says the $4.8 billion company “consistently and at times egregiously put profits and growth before patient safety."
Subscribe to:
Post Comments (Atom)
< + > Beyond the Science by Gary Zammit – Life Sciences Today Podcast Episode 46
We’re excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Gary Zammit, PhD,...
No comments:
Post a Comment